Azierta Life Sciences & Health Consulting Firm
Azierta Life Sciences & Health Consulting Firm is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
A Phase II clinical trial targeting estrogen receptor negative or PAM50 non-luminal disease with Atezolizumab in combination with Trastuzumab and Vinorelbine in HER2-positive advanced/metastatic breast cancer – ATREZZO Study
Sponsor Solti Group
- Start (EU)
- Latest update
- Estimated end
- Not reported
Phase II, multicenter, randomized, open-label study of premenopausal women with luminal breast cancer investigating the effect of oral SERD elacestrant with/without triptorelin in the ER functional pathway and Ki67 proliferation. Preoperative trial – PremiÈRe
Sponsor Solti Group
- Start (EU)
- Latest update
- Estimated end
- Not reported
LATE-R TRIAL: A PHASE II, SINGLE-ARM, OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE EFFICACY OF AXICABTAGENE CILOLEUCEL IN PATIENTS WITH LATE RELAPSE OF DIFFUSE LARGE B-CELL LYMPHOMA
Sponsor Fundacion Geltamo
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Azierta Life Sciences & Health Consulting Firm?
The 2026-10-09 snapshot links Azierta Life Sciences & Health Consulting Firm to 3 distinct CTIS trials. Recorded services include Safety reporting & pharmacovigilance. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Azierta Life Sciences & Health Consulting Firm?
Therapeutic-area tags are not recorded in this snapshot. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Azierta Life Sciences & Health Consulting Firm conducted?
The linked trials record locations in 1 country, including Spain. These are trial locations, not confirmed office locations or countries where Azierta Life Sciences & Health Consulting Firm delivered services.
What can this page tell me about Azierta Life Sciences & Health Consulting Firm's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Azierta Life Sciences & Health Consulting Firm. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Azierta Life Sciences & Health Consulting Firm S.L.